Topic: artificial intelligence
Our goal is to assess how far the adoption of AI technology has come in Life Sciences.
Daphne Koller, CEO, Insitro
Novartis’ new collab with Microsoft leverages AI to streamline drug discovery, but the joint effort goes beyond just finding new treatments.
AstraZeneca is enlisting artificial intelligence to coach its sales reps using data generated from thousands of field-coaching forms.
Pharma customer service reps can’t just Google the answers to doctor questions about their company's drugs. But now, at Biogen, they can.
BeiGene rebuffs claims that it inflated drug sales records; Sumitomo Dainippon pays $3 billion upfront for five "vants"; Genentech settles with JHL Biotech.
Biocon's manufacturing problems cost it and Mylan again; CStone's CEO racks up nearly $20 million in 2018 pay; Novartis sells Suzhou plant.
Sun's Shanghvi took a 99% pay cut last year. Dr. Reddy's copies of Copaxone and NuvaRing were rejected by the FDA. Natco eyes China amid hardship.
Consultancy ZS recently launched an editorial series called "AI &" to dive into artificial intelligence best practices for pharma.
Join this webinar to learn the five characteristics of a unified platform and how each benefits clinical research both for a single trial and across your suite of research efforts.